Copy
2015 Prostate Cancer Conference | Tomasz Beer, MD
View this email in your browser

2015 PROSTATE CANCER CONFERENCE

           THE #1 PROSTATE CANCER CONFERENCE FOR PATIENTS

REGISTER NOW

FEATURED SPEAKER: DR. TOMASZ BEER
TOPIC: HORMONE RESISTANCE 

We are thrilled to have Dr. Tomasz Beer joining us this year at the 2015 Patient Prostate Cancer Conference to speak about Zytiga & Xtandi. 

Tomasz Beer, MD is the Grover C. Bagby Endowed Chair for Prostate Cancer Research, Professor of Medicine, Division of Hematology & Medical Oncology, and Deputy Director at the Oregon Health & Science University Knight Cancer Institute in Portland, Oregon.

Dr. Beer has authored and co-authored more than 300 articles and abstracts on prostate cancer largely focusing on the development of novel therapies through clinical and translational investigation. He recently co-authored the book Cancer Clinical Trials: A Commonsense Guide to Experimental Cancer Therapies and Clinical Trials. Dr. Beer’s major research interests include clinical trials, preclinical investigation, and risk factors in prostate cancer. Dr. Beer was also selected as one of six top scientists to take part in a research Dream Team that joins together world-class institutions to study treatments for advanced prostate cancer.

Dr. Beer is a specialist in prostate cancer care. In a recent interview with ascopost.com, Dr. Beer noted that both abiraterone (Zytiga) and enzalutamide (Xtandi) have shown benefit in docetaxel-naive patients with metastatic disease, yet presently there are no head-to-head comparisons to guide treatment selection. He added “We have two active drugs for patients. My hope is that our future studies will further define which patients benefit from which approach. For now, we have encouraging results for both drugs and we will treat patients by making decisions one at a time.”

Don’t miss Dr. Tomasz Beer on Saturday, September 12, as well as many other esteemed prostate cancer experts covering a wide variety of topics, including: Chemotherapy, Xofigo, Bone Health, Immune Therapy, Seed Implant Radiation, Active Surveillance, and managing the sexual side effects of treatment.

PCRI Casino Night

Try your luck at our first ever Casino Night! Relax and enjoy your first night of the conference before a busy weekend! Craps! Blackjack! Roulette! Music! Meet old friends and make new ones! Free desserts and coffee! Other drinks will be available at the cash bar. You can add the casino night to your agenda when registering for the conference. If you would like to add the casino night to your current registration, please call us at 310-743-2116. The event will be from 7:00 pm to 10:00 pm on Friday night.
 
Book Your Excursion
Copyright © 2015 Prostate Cancer Research Institute, All rights reserved.


unsubscribe from this list    update subscription preferences